MedPath

Jilin Jian Yisheng Pharmaceutical CO.,LTD.

🇨🇳China
Ownership
-
Established
1997-06-11
Employees
1.3K
Market Cap
-
Website
www.yisheng-pharm.com
Introduction

At the beginning of its establishment, the company set out to “take root in traditional culture, rely on modern technology, and build a complete ginseng industry chain” as its development strategy, aiming to build the number one brand in the Chinese ginseng industry and a first-class brand in the world's ginseng industry. To achieve its strategic goals, the company has built a cultural system with the corporate purpose of “inheriting Chinese civilization and serving human health”; “dedication, teamwork and innovation” as the enterprise spirit; and “caring for all people, honesty and sincerity, putting people first, and putting innovation first” as the core concept. The company's main business is research and development, production and sales of pharmaceuticals. The company's main products include Zhenyuan capsules, Xinyue capsules, fresh hemorrhoid injections, red ginseng and wheat dong cream, red ginseng extract plant drink, Airun, Dayang Hero, Guowei lemon powder, red ginseng, jujube, poria cocos plant drink, Isanio Red Ginseng Nourishing Series, Ginseng Snow Skin Series, Pine Rose Beauty Series, Ginseng Fruit Nourishing Series, Fish Seed Nourishing Series and Gold Recovery Series, Luxury Lotus Luxury Hydrating Series, Luxury Lotus Luxury Hydrating Series, Luxury Lotus Xiuhong series, Luxurious Lotus Xinyang Shuiyuan series, Red ginseng snail series, propolis series, pomegranate series, Wei His Vivid Collection. Corporate honors: In January 2013, Yisheng Pharmaceutical was recognized as the “Advanced Unit for the Revitalization of the Ginseng Industry in Jilin Province”; in May 2013, Yisheng Pharmaceutical was recognized as the “Best Small and Medium Board Enterprise Award”; in January 2015, Yisheng Pharmaceutical was recognized as the “AAA-level Integrity Unit in Jilin Province”; in November 2015, Yisheng Pharmaceutical was recognized as a “contract-abiding and credit-worthy” AAA enterprise in Jilin Province; in July 2016, Yisheng Pharmaceutical was recognized as the “Excellent Model Chinese Medicine AAA Quality Credit Demonstration Unit” in Jilin Province; in July 2016, Yisheng Pharmaceutical was recognized as the “Excellent Model Chinese Medicinal Material” AAA Quality Credit Demonstration Unit in Jilin Province; in July 2016, Yisheng Pharmaceutical was recognized as the “Excellent Model Chinese Medicinal Material” AAA Quality Credit Demonstration Unit in Jilin Province; “Planting base”, national high-tech Honorary title of technology enterprise, title of key leading enterprise in agricultural industrialization at the municipal level, “Tonghua Specialized and New Enterprise”, “National Intellectual Property Advantage Enterprise”, “Cosmetics Production Demonstration Base”, etc.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

136

NMPA:136

Drug Approvals

除脂生发片

Approval Number
国药准字Z22025441
Approval Date
Nov 7, 2022
NMPA

Fleroxacin Injection

Product Name
氟罗沙星注射液
Approval Number
国药准字H20123262
Approval Date
Jul 26, 2022
NMPA

Simvastatin Tablets

Product Name
辛伐他汀片
Approval Number
国药准字H20123071
Approval Date
Jan 11, 2022
NMPA

益盛汉参牌人参红景天灵芝颗粒

Approval Number
国食健注G20150778
Approval Date
Jan 7, 2021
NMPA

Isosorbide Mononitrate Injection

Product Name
单硝酸异山梨酯注射液
Approval Number
国药准字H20103698
Approval Date
Nov 16, 2020
NMPA

Furosemide Injection

Product Name
呋塞米注射液
Approval Number
国药准字H22021500
Approval Date
Nov 16, 2020
NMPA

Ethylencdiamine Diaceturate Injection

Product Name
二乙酰氨乙酸乙二胺注射液
Approval Number
国药准字H20043340
Approval Date
Nov 16, 2020
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H22021499
Approval Date
Nov 16, 2020
NMPA

Ethylenediamine Diaceturate Injection

Product Name
二乙酰氨乙酸乙二胺注射液
Approval Number
国药准字H22024092
Approval Date
Nov 16, 2020
NMPA

生脉注射液

Approval Number
国药准字Z22026097
Approval Date
Jul 23, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.